A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
High cholesterol fluctuations have been linked to a higher risk of developing dementia, including Alzheimer's and vascular dementia. Maintaining stable cholesterol levels through a healthy diet, ...